Showing 51-60 of 2352 results for "".
Seeking Breakthroughs: The Startup Perspective
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-startup-perspective/30194/A roundtable discussion with Chase Spurlock, PhD, IQuity; Michal Izrael, PhD, Kadimastem Ltd; Kevin Hrusovsky, Quanterix; and J. Michael Ryan, MD, Rodin TherapeuticsConcussion and Epilepsy: What is the Link?
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/concussion-and-epilepsy-what-is-the-link/30769/Individuals who suffer a traumatic brain injury are at increased risk for developing seizures. Here's an update to the current evidence and implications for monitoring.Insights from G. Alexander Hishaw, MDAbout the Cover Artist
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/audrius-v-plioplys-md-is-a-neurologist-who-has-merged-the-research-lab-with-the-art-studio/31667/Audrius V. Plioplys, MD, is a neurologist who has merged the research lab with the art studio.Rett Syndrome: Magnolia and Her Family's Experience
https://practicalneurology.com/diseases-diagnoses/movement-disorders/rett-syndrome-magnolia-and-her-familys-experience/30097/AJ Tesler shares the story of his daughter, Magnolia, who is living with Rett syndrome. As a parent and caregiver, AJ provides his perspective throughout the diagnostic and therapeutic journey for Rett syndrome and is joined by Rett syndrome expert Carey Fu, MD, Pediatric Neurologist at Vanderbilt UThe Importance of Early Diagnosis and Treatment of Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-importance-of-early-diagnosis-and-treatment-of-alzheimer-disease/35436/Linda Shows, a semi-retired nurse who lives with mild cognitive impairment, and her physician, Wendell Helveston, MD, Hattiesburg Clinic, Hattiesburg, MS, discuss the importance of early diagnosis and treatment in Alzheimer disease, including other factors that can help patients thrive when living wSMA Experience: Episode 2
https://practicalneurology.com/diseases-diagnoses/neuromuscular/sma-experience-episode-2/30081/Neuromusclar disease expert Diana Bharucha-Goebel, MD, PhD chats with Traci High, mother of two patients with SMA about how the SMA treatment landscape, and her childens' lives, have changed over the past 15 years.Promising Results for Investigational Antisense Oligonucleotide Treatment for Dravet Syndrome
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/promising-results-for-investigational-antisense-oligonucleotide-treatment-for-dravet-syndrome-1/35435/Joseph Sullivan, MD, Professor, UCSF School of Medicine, San Francisco, CA, describes encouraging results from the SWALLOWTAIL and LONGWING studies of an investigational treatment for individuals with Dravet syndrome, including outcomes related to seizure frequency, cognition, and behavior.Emerging Use of Ketamine for the Treatment of Migraine and Other Headache Disorders
https://practicalneurology.com/programs/practical-neurology/emerging-use-of-ketamine-for-the-treatment-of-migraine-and-other-headache-disorders/35431/Peter McAllister, MD, FAAN, Chief Medical Officer of the New England Institute for Neurology and Headache, Stamford, CT, discusses the application of ketamine in neurologic practice for the treatment of migraine and other headache disorders, including experiences from his clinical practice.The Evolving Therapeutic Landscape for Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/the-evolving-therapeutic-landscape-for-parkinson-disease/36164/Mark Stacy, MD, William E. Murray Professor of Neurology, Medical University of South Carolina, Charleston, SC, discusses the evolving therapeutic landscape for Parkinson disease, highlighting promising advances in neuroprotective therapies, biomarkers, personalized medicine, and innovative clinicalModern Glioma Management: Integrating Molecular Markers and New Targeted Therapies
https://practicalneurology.com/diseases-diagnoses/neuro-oncology/modern-glioma-management-integrating-molecular-markers-and-new-targeted-therapies/48967/Patrick Y. Wen, MD, Dana-Farber Cancer Institute, Boston, MA, discusses current standards of care for low- and high-grade gliomas, including the importance of comprehensive molecular testing, the World Health Organization classification of tumors of the central nervous system, and newly available th